This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UPDATE -- Covisint Launches Alliance With Milliman, Inc.

DETROIT, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, today announced a new alliance with Milliman, Inc., a premier global consulting and actuarial firm. Milliman's innovative opportunity-based population analytics capabilities will now be integrated into the Covisint Healthcare platform, extending Covisint's population and risk management capabilities as a catalyst to help accountable care organizations (ACOs) achieve their full potential.
Compuware Logo
Covisint Logo

ACOs traditionally lack the ability to predict cost implications and savings, which has been a barrier to gaining provider support and engagement. By delivering predictive analytics at the point of care, ACOs can address key business and financial challenges.

"The relationship with Covisint makes Milliman's opportunity-based population analytics available at the point of care," said Art Wilmes, FSA, MAAA and a Principal and Consulting Actuary for Milliman. "This relationship expands Milliman's ACO offerings—which include actuarial and healthcare consulting as well as financial and clinical analytics—by helping ACOs to use additional care management to reduce avoidable costs in patient populations. Rather than just identifying the highest-cost patients, our approach focuses on the optimal deployment of care management teams and on identifying opportunities to 'bend the cost curve.'"

"This alliance will help ACOs achieve critical goals, in particular by satisfying their need to improve their quality of care and avoid unnecessary costs. Our alliance with Milliman extends Covisint's ability to drive deep value to the accountable care equation as we are now able to identify chronic populations, predict outcomes and conduct population health management," said Steve McDonald, Vice President of Healthcare for Covisint. "This is a powerful differentiator that, we believe, nobody else can do, and it reflects Covisint's continued commitment to bring innovative healthcare solutions to market through our cloud-based platform."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs